LACEY WEST: Open Payments
NPI 1154018737 · WINTERS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 26 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $246 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $162 |
| AstraZeneca Pharmaceuticals LP | 2 | $154 |
| Verona Pharma, Inc. | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Insmed, Inc. | 1 | $31 |
| GENZYME CORPORATION | 1 | $23 |
Products named: FASENRA, TRELEGY ELLIPTA, Ohtuvayre, OFEV, NUCALA, Arikayce, DUPIXENT, AREXVY.
Industry payments across TX — which companies pay providers there.
